Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis

Recent evidence indicates that metformin therapy may be associated with a decreased colorectal adenoma/colorectal cancer risk in type 2 diabetes patients. However, results are not consistent. We therefore performed a systematic review and meta-analysis to assess the association between metformin the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Feifei, Yan, Lijing, Wang, Zhan, Lu, Yuanan, Chu, Yuanyuan, Li, Xiangyu, Liu, Yisi, Rui, Dongsheng, Nie, Shaofa, Xiang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362542/
https://www.ncbi.nlm.nih.gov/pubmed/27926481
http://dx.doi.org/10.18632/oncotarget.13762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362542/
https://www.ncbi.nlm.nih.gov/pubmed/27926481
http://dx.doi.org/10.18632/oncotarget.13762

Ejemplares similares